The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study

Objective To evaluate the beneficial effects of Implanon on pelvic pain in women with pelvic congestion syndrome (PCS). The efficacy of pain control, amount and frequency of menstrual loss, degree of patient’s satisfaction and objective pelvic venography scores were investigated.

In a prospective open-labelled study, 25 consecutive women complaining of chronic pelvic pain were recruited. Pretreatment objective peruterine venography and diagnostic laparoscopy of pure PCS together with subjective pelvic pain scores, prefilled questionnaire of Hospital Anxiety and Depression Scale (HADS), visual analogue scale (VAS), verbal rating scale (VRS) and quantified menstrual loss using the pictorial blood loss chart were documented in all cases. After identification, 23 subjects with pure PCS were randomly assigned to have either Implanon inserted subcutaneously (12 cases) or no treatment (11 cases). Patients were followed up at 1, 3, 6, 9 and 12 months. A symptom diary for side effects, VAS, VRS and menstrual scores were used to assess the subjective response to treatment. At the end of the study, all patients underwent repeat venography to assess the long-term objective response. After 12 months, subjects having Implanon inserted were requested to rate their overall degree of satisfaction with therapy.

All 25 women recruited in the study completed follow-up. Two cases were excluded from the study and referred to the psychiatry department after a negative evaluation for disease and HADS scores relevant for depression. An improvement in symptoms was observed throughout the 12 months amongst the Implanon group versus no treatment. The greatest changes in pain assessed using either the VAS or VRS were between the pretreatment scores and those after 6 months (7.7 ± 1.3 vs. 4.6 ± 3.0 for VAS, P < 0.001; and 25 ± 13.8 vs. 19 ± 18.9 for VRS, P < 0.002). The monthly quantified blood loss fell from 204 (196) pretreatment to 90 (157) at 6 months (P < 0.001) and then to 64 (32) at 9 months (P < 0.002). Objective repeat venography score was reduced significantly at 1 year after treatment compared with the baseline evaluation as well as with the control group (4.5 ± 1.2 vs. 8.6 ± 0.5; P = 0.001 and 4.2 ± 0.9 vs. 8.5 ± 0.6; P = 0.0002, respectively). At final satisfaction assessment, 2 (17%) women were very satisfied 8 (66%) were satisfied, and 2 (17%) were uncertain. The implant was retained by all women at the end of the study.

Implanon seems to be an effective hormonal alternative for long-term treatment of properly selected patients with pure PCS-related pelvic pain. Similar content being viewed by others Change history 01 August 2023 An Editorial Expression of Concern to this paper has been published: https://doi.org/10.1007/s00404-023-07157-8

Nicholson T, Basile A (2006) Pelvic congestion syndrome, who should we treat and how? Tech Vasc Interv Radiol 9:19–23. doi:10.1053/j.tvir.2006.08.005 Cheong Y, William Stones R (2006) Chronic pelvic pain: aetiology and therapy. Best Pract Res Clin Obstet Gynaecol 20:695–711. doi:10.1016/j.bpobgyn.2006.04.004 Lukanova M, Popov I (2008) Chronic pelvic pain and combined oral hormonal contraception. Akush Ginekol (Sofiia) 47:20–29 Ferrero S, Ragni N, Remorgida V (2008) Deep dyspareunia: causes, treatments, and results. Curr Opin Obstet Gynecol 20:394–399 Beard RW, Reginald PW, Wadsworth J (1988) Clinical features of women with chronic lower abdominal pain and pelvic congestion. Br J Obstet Gynaecol 95:153–161 Simsek M, Burak F, Taskin O (2007) Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial. Clin Exp Obstet Gynecol 34:96–98 Beard RW, Reginald PW, Pearce S (1986) Pelvic pain in women. Br Med J (Clin Res Ed) 283:160–162 Soysal ME, Soysal S, Vicdan K, Ozer S (2001) A randomized controlled trial of goserelin and medroxyprogesterone acetate in the treatment of pelvic congestion. Hum Reprod 16:931–939. doi:10.1093/humrep/16.5.931 Farquhar CM, Rogers V, Franks S, Pearce S, Wadsworth J, Beard RW (1989) A randomized controlled trial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion. Br J Obstet Gynaecol 96:1153–1162 Reginald PW, Adams J, Franks S, Wadsworth J, Beard RW (1989) Medroxyprogesterone acetate in the treatment of pelvic pain due to venous congestion. Br J Obstet Gynaecol 96:1148–1152 Wagner MS, Arias RD, Nucatola DL (2007) The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring. Expert Opin Pharmacother 8:1769–1777. doi:10.1517/14656566.8.11.1769 Power J, French R, Cowan F (2007) Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 3:CD 001326 Gezginc K, Balci O, Karatayli R, Colak-Oglu MC (2007) Contraceptive efficacy and side effects of Implanon. Eur J Contracept Reprod Health Care 16:1–4 Affandi B (1998) An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contracept Suppl 58:99–101 Higham J, O’Brien PM, Shaw RW (1990) Assessement of menstrual loss using a pictorial chart. Br J Obstet Gynaecol 97:734–739 Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370. doi:10.1111/j.1600-0447.1983.tb09716.x Adams J, Reginald PW, Franks S, Wadsworth J, Beard RW (1990) Uterine size and endometrial thickness and the significance of cystic ovaries in women with pelvic pain due to congestion. Br J Obstet Gynaecol 97:583–587 Stones RW, Mountfield J (2000) Interventions for treating chronic pelvic pain in women. Cochrane Database Syst Rev (4):CD 000387 Pilawski Z, Sieja K, kosmider M (1987) Pelvic congestion as a symptom of psychsomatic disorders. Pol Tyg Lek 42:1156–1158 Beard R, Reginald P, Pearce S (1988) Psychological and somatic factors in women with pain due to pelvic congestion. Adv Exp Med Biol 245:413–421 Ganeshan A, Upponi S, Hon LQ, Uthappa MC, Warakaulle DR, Uberoi R (2007) Chronic pelvic pain due to pelvic congestion syndrome: the role of diagnostic and interventional radiology. Cardiovasc Intervent Radiol 30:1105–1111. doi:10.1007/s00270-007-9160-0 Conflict of interest statement There is no actual or potential conflict of interest in relation to this article. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Shokeir, T., Amr, M. & Abdelshaheed, M. The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study. Arch Gynecol Obstet 280, 437–443 (2009). https://doi.org/10.1007/s00404-009-0951-1 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-009-0951-1